Granted Patent B2

US 12,545,956 · App. 18/991,325 · Granted Feb 10, 2026

Inventors: Stuart William Reid (Oxford, GB); Gavin Harper (Oxford, GB); Clive Gavin Brown (Oxford, GB); Daniel John Turner (Oxford, GB); Andrew John Heron (Oxford, GB); Christopher James Wright (Oxford, GB)

Assignee: Oxford Nanopore Technologies PLC

C12Q1/6869G01N33/48721G16B30/00G16B30/10

Abstract

Claims (83)

1 . A method of controlling a biochemical analysis system for screening of a plurality of polymers, the plurality of polymers comprising a first polymer, the biochemical analysis system comprising a nanopore, the method comprising:

(A) during translocation of the first polymer through the nanopore,

making a series of measurements corresponding to a portion of the first polymer that has been translocated through the nanopore;

determining a measure of similarity between the portion of the first polymer and at least one reference sequence of polymer units by using the series of measurements obtained and reference data derived from the at least one reference sequence of polymer units; and

determining, using the measure of similarity, whether to eject the first polymer from the nanopore or continue translocating the first polymer through the nanopore; and

(B) based on the determination made using the measure of similarity, either:

ejecting the first polymer from the nanopore, or

further translocating the first polymer through the nanopore.

2 . The method of claim 1 , wherein:

the plurality of polymers comprise a sample extracted from a human;

the at least one reference sequence of polymer units comprises human DNA; and

the determining, using the measure of similarity, whether to eject the first polymer comprises:

determining to eject the first polymer from the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising human DNA, that the first polymer comprises human DNA; and

determining to further translocate the first polymer through the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising human DNA, that the first polymer does not comprise human DNA.

3 . The method of claim 1 , wherein:

the plurality of polymers comprise a sample extracted from a food product;

the at least one reference sequence of polymer units comprises nucleic acid of a contaminant; and

the determining, using the measure of similarity, whether to eject the first polymer comprises:

determining to eject the first polymer from the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the nucleic acid of the contaminant, that the first polymer comprises the contaminant; and

determining to further translocate the first polymer through the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the nucleic acid of the contaminant, that the first polymer does not comprise the nucleic acid of the contaminant.

4 . The method of claim 3 , wherein the contaminant is a non-food product.

5 . The method of claim 3 , wherein the food product comprises a first meat product.

6 . The method of claim 5 , wherein the contaminant is a second meat product that is different from the first meat product.

7 . The method of claim 1 , wherein:

the plurality of polymers comprise DNA;

the at least one reference sequence of polymer units comprises a target gene; and

the determining, using the measure of similarity, whether to eject the first polymer comprises:

determining to eject the first polymer from the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the target gene, that the first polymer does not comprise the target gene; and

determining to further translocate the first polymer through the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the target gene, that the first polymer comprises the target gene.

8 . The method of claim 1 , wherein:

the plurality of polymers comprise a sample extracted from bacteria;

the at least one reference sequence of polymer units comprises an antibiotic resistant gene; and

the determining, using the measure of similarity, whether to eject the first polymer comprises:

determining to eject the first polymer from the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the antibiotic resistant gene, that the first polymer does not comprise the antibiotic resistant gene; and

determining to further translocate the first polymer through the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the antibiotic resistant gene, that the first polymer comprises the antibiotic resistant gene.

9 . The method of claim 1 , wherein:

the plurality of polymers comprise RNA;

the at least one reference sequence of polymer units comprises mRNA; and

the determining, using the measure of similarity, whether to eject the first polymer comprises:

determining to eject the first polymer from the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the mRNA, that the first polymer does not comprise mRNA; and

determining to further translocate the first polymer through the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising mRNA, that the first polymer comprises mRNA.

10 . The method of claim 1 , wherein the method further comprises selecting the at least one reference sequence based on the series of measurements.

11 . The method of claim 10 , wherein the plurality of polymers comprise a sample extracted from bacteria, the at least one reference sequence is selected based on a determined strain of the bacteria, and the method is for phenotyping the sample or for detecting a single-nucleotide polymorphism in the sample.

12 . The method of claim 1 , wherein:

the plurality of polymers comprise a sample extracted from a patient having cancer;

the at least one reference sequence of polymer units comprises at least one gene associated with a class of cancer; and

the determining, using the measure of similarity, whether to eject the first polymer comprises:

determining to eject the first polymer from the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the at least one gene associated with a class of cancer, that the first polymer does not comprise the at least one gene associated with a class of cancer; and

determining to further translocate the first polymer through the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the at least one gene associated with a class of cancer, that the first polymer comprises the at least one gene associated with a class of cancer.

13 . The method of claim 12 , further comprising:

determining a second measure of similarity between the portion of the first polymer and at least one second reference sequence of polymer units by using the series of measurements obtained and second reference data derived from the second at least one second reference sequence, wherein the at least one second reference sequence comprises a sequence of polynucleotides associated with a sub-class of the class cancer;

determining to eject the first polymer from the nanopore when it is determined, using the second measure of similarity to the at least one second reference sequence of polymer units comprising the sequence of polynucleotides associated with the sub-class of the class of cancer, that the first polymer does not comprise the sequence of polynucleotides associated with the sub-class of the class of cancer; and

determining to further translocate the first polymer through the nanopore when it is determined, using the second measure of similarity to the at least one second reference sequence of polymer units comprising the sequence of polynucleotides associated with the sub-class of the class of cancer, that the first polymer comprises the sequence of polynucleotides associated with a sub-class of the class of cancer.

14 . The method of claim 1 , wherein:

the at least one reference sequence of polymer units comprises a target analyte, wherein at least a threshold percent of nucleotides in the at least one reference sequence are Guanines and Cytosines; and

the determining, using the measure of similarity, whether to eject the first polymer comprises:

determining to eject the first polymer from the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the target analyte, that the first polymer does not comprise the target analyte; and

determining to further translocate the first polymer through the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the target analyte, that the first polymer comprises the target analyte.

15 . The method of claim 1 , wherein the further translocating comprises further translocating the first polymer through the nanopore at an increased rate and/or without making further measurements of the first polymer.

16 . The method of claim 1 , wherein:

the at least one reference sequence of polymer units comprises a sequence of polymer units of the first polymer previously measured by the biochemical analysis system;

determining to eject the first polymer from the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the sequence of polymer units of the first polymer previously measured by the biochemical analysis system, that the first polymer comprises the at least one reference sequence of polymer units comprising the sequence of polymer units of the first polymer previously measured by the biochemical analysis system; and

determining to further translocate the first polymer through the nanopore when it is determined, using the measure of similarity to the at least one reference sequence of polymer units comprising the sequence of polymer units of the first polymer previously measured by the biochemical analysis system, that the first polymer does not comprise the at least one reference sequence of polymer units comprising the sequence of polymer units of the first polymer previously measured by the biochemical analysis system.

17 . The method of claim 16 , further comprising obtaining the at least one reference sequence of polymer units at least in part by:

translocating the first polymer through the nanopore; and

making a second series of measurements corresponding to a second portion of the first polymer that has been translocated through the nanopore.

18 . A method of controlling a biochemical analysis system for screening of a plurality of polymers, the plurality of polymers comprising a first polymer, the first polymer being obtained from a sample obtained from a patient, the biochemical analysis system comprising a nanopore, the method comprising:

(A) during translocation of the first polymer through the nanopore,

making a series of measurements corresponding to a portion of the first polymer that has been translocated through the nanopore; and

determining a measure of similarity between the portion of the first polymer and at least one reference sequence of polymer units by using the series of measurements obtained and reference data derived from the at least one reference sequence of polymer units of a target polymer; and

(B) based on the determined measure of similarity, determining a diagnosis of the patient; and

(C) outputting the determined diagnosis of the patient.

19 . The method of claim 18 , wherein the determining the diagnosis of the patient based on the determined measure of similarity comprises determining a presence or absence of the target polymer in the sample obtained from the patient.

20 . A biochemical analysis system configured to screen a plurality of polymers, the plurality of polymers comprising a first polymer, the biochemical analysis system comprising:

a nanopore; and

at least one controller configured to:

(A) during translocation of the first polymer through the nanopore,

make a series of measurements corresponding to a portion of the first polymer that has been translocated through the nanopore;

determine a measure of similarity between the portion of the first polymer and at least one reference sequence of polymer units by using the series of measurements obtained and reference data derived from the at least one reference sequence of polymer units; and

determine, using the measure of similarity, whether to eject the first polymer from the nanopore or continue translocating the first polymer through the nanopore; and

(B) based on the determination made using the measure of similarity, either:

eject the first polymer from the nanopore, or

further translocate the first polymer through the nanopore.

Assignments (2)

Priority Claims (3)

Continuity (4)

References Cited (232)